CHMP gives Sanofi positive opinion for Sarclisa
Despite available treatments, multiple myeloma remains an incurable malignancy, and is associated with significant patient burden.
27th March 2020
Latest news
BMJ journal deems opioid dependency implant more favourable than tablets
While the opioid epidemic in the USA is well documented, Europe also has an estimated 1.3 million high-risk opioid users.
27th March 2020
Takeda, Evox link up to the tune of $882m
Evox will offer its preclinical programme in Niemann-Pick disease type C for development, and a second new programme directed at another undisclosed rare disease.
27th March 2020
EMA accepts Arvelle’s cenobamate MAA
There are about six million people in Europe with epilepsy, and approximately 40% of adults with focal-onset seizures continue to experience seizures.
27th March 2020
COVID-19: ‘Army’ of volunteers join NHS as BMS postpones new study starts
The FDA has also granted Gilead's wishes to withdraw orphan drug designation for remdesivir under current circumstances.
26th March 2020
Astellas, CytomX form T-cell engaging cancer antibodies partnership
Astellas has confirmed that it will make an upfront cash payment of $80 million to CytomX.
26th March 2020
Novavax plans FDA filing after NanoFlu trumps Sanofi flu vaccine
The vaccine met all primary endpoints in adults aged 65 and older against Sanofi’s Fluzone Quadrivalent.
26th March 2020
Botox gets license update in UK
Previously the licence referred to “physicians”, prompting confusion over who is able to inject the treatment.
26th March 2020
Bayer enlists Curadev in STING antagonist collaboration
STING is known to play a role in activating the innate immune system in auto-inflammatory diseases.
25th March 2020
Hep C cases down around 70% in HIV positive men in London and Brighton
Regular hepatitis C screening and improved access to new treatments has potentially contributed to greatly reducing the transmission of the infection.
25th March 2020
COVID-19: AstraZeneca to distribute masks as ASCO goes virtual
PHE has also been awarded $500,000 by the US FDA to bolster the international response.
25th March 2020
AZ to develop siRNA with Silence Theraputics
siRNA are double-stranded RNA molecules that offer new opportunities for therapeutic intervention because they act inside the cell to influence protein production.
25th March 2020
Venclexta/Venclyxto combo extends myeloid leukaemia survival
Roche also reported that safety for Venclexta/Venclyxto with azacitidine appeared consistent with the known safety profile of these medicines.
24th March 2020
COVID-19: Gilead deals with ‘overwhelming’ remdesivir demands, Eli Lilly halts trial enrolment
The current recorded case count for COVID-19 (coronavirus) in the UK has hit 6,650, with 335 deaths and 135 recoveries.
24th March 2020
COVID-19: NIHR awards £10.5m to six new projects as NHS receives more protective equipment
One of the projects will investigate potential vaccines, and could begin as early as June.
24th March 2020
